Health

Saudi Arabia records 3,852 new COVID-19 cases, four deaths in 24 hours

Saudi Arabia has recorded 3,852 new COVID-19 cases and four virus-related deaths, according to the Kingdom’s Ministry of Health.

For the latest headlines, follow our Google News channel online or via the app.

A total of 699,069 COVID-19 cases and 8,947 virus-related deaths have now been recorded in Saudi Arabia since the beginning of the pandemic.

In the last 24 hours there were also 4,368 recoveries, bringing the total number of recoveries to 653,972.

The Kingdom has now administered 57,843,209 vaccine doses to its population of around 35 million, the health ministry said.

A booster shot has been required to attain the ‘immune’ status in the country’s contact-tracing "Tawakkalna" app since Tuesday, for those over 18 who had their second vaccine dose more than eight months ago.

An ‘immune’ status is required to enter certain public places, use public transport, and enter government buildings in the country.

US considers authorization of first COVID-19 vaccine for children under 5

Booster shot now required for ‘immune’ ‘Tawakkalna’ status in Saudi Arabia

Health

‘Just in case’ use of antibiotics was rife during COVID-19, says UN health agency

Antibiotics saw “extensive overuse” globally among hospitalized COVID-19 patients during the pandemic without improving clinical outcomes, while also potentially exacerbating the already serious and growing threat of antimicrobial resistance, the UN World Health Organization (WHO) said on Friday.

Health

Teen alcohol and nicotine use in Europe is up, WHO urges preventive measures

Substance use is on the rise among teenagers in Europe, Central Asia and Canada and girls now match or even exceed boys when it comes to smoking and drinking, the World Health Organization (WHO) said in a new report on Thursday.

Health

Gender therapy review reveals devastating impacts on teens

A top Human Rights Council-appointed expert has welcomed the decision by all health authorities in the United Kingdom to halt the routine use of puberty-blockers offered to children as part of gender transition services, amid a sharp increase more widely in the number of teenage girls seeking such treatment and concerns that it might disrupt brain development.